InvestorsHub Logo
icon url

petemantx

02/10/21 12:12 PM

#345259 RE: Hugon #345229

Where the hell did you get the information that Brilacidin (ABSSSI)results were inferior to Daptomyacin?

1 dose of Brilacidin was shown to be equivalent to an entire week of daptomyacin dosing.

The ONLY reason ABSSSI has been sitting on the shelf is lack of money. Daptomyacin still cannot equal Brilacidin in preventing a virus by building up a resistance and that is why Daptomyacin is still used so sparingly. Major major advantage to Brilacidin.
icon url

Jhawker

02/10/21 12:41 PM

#345265 RE: Hugon #345229

What you meant to say is non-inferior